Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cystic Fibrosis Foundation

Thumbshot of's website
http://www.cff.org

NIH Director Francis Collins to Address 3,000 Cystic Fibrosis Experts at International Conference in Minneapolis

Thursday 8th of October 2009 10:30

-- Coping with barriers to health care coverage for people with CF

Cystic fibrosis affects about 30,000 children and adults in the United States and causes life-threatening lung infections and premature death. Ten million people are unknowing carriers of the faulty CF gene. Fifty years ago, most children with CF died before reaching elementary school. Today, because of Cystic Fibrosis Foundation-supported drug research and care, people with CF are living into their 30s, 40s and beyond.

WHAT:

The North American Cystic Fibrosis Conference, the largest international gathering of leading cystic fibrosis research scientists and clinicians.

WHEN & WHERE:

Thurs., Oct. 15 - Sat., Oct. 17, 2009, at the Minneapolis Convention Center, Minneapolis, Minnesota.

PLENARY SESSION HIGHLIGHTS:

    --  Thursday, Oct. 15, 4:20 p.m. - Francis S. Collins, M.D., Ph.D., the
        National Institutes of Health,  and Steven M. Rowe, M.D., MSPH, The
        University of Alabama at Birmingham: "Two Decades of CFTR Research: From
        Gene Discovery to Therapeutic Target."
    --  Friday, Oct. 16, 8:45 a.m. - Michael W. Konstan, M.D., Rainbow Babies &
        Children's Hospital, Cleveland, Ohio and Lisa Saiman, M.D., M.P.H.,
        Columbia University College of Physicians & Surgeons, New York, New
        York: "Inflammation & Infection: Update on the Pipeline."

    --  Sat., Oct. 17, 8:30 a.m. - Bonnie W. Ramsey, M.D., Children's Hospital &
        Regional Medical Center, Seattle, Washington, George Z. Retsch-Bogart,
        M.D., University of North Carolina, Chapel Hill, North Carolina and
        Claire E. Wainwright, M.D., MBBS, Royal Children's Hospital, Brisbane,
        Queensland, Australia: "Early Airway Infection in Young Children with CF
        - What is the Optimal Therapy?"

INTERVIEWS AVAILABLE WITH:

    --  Plenary speakers and other leading CF research scientists and clinicians
    --  Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation
    --  Preston W. Campbell, M.D., Executive Vice President for Medical Affairs,
        Cystic Fibrosis Foundation

    --  Patient interviews available upon request

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available today was made possible because of Foundation support. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. For more information, visit www.cff.org.

SOURCE Cystic Fibrosis Foundation


Browse other news from this organisation: Cystic Fibrosis Foundation

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2009

Download PDF PDF Version

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.